These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9147501)

  • 21. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
    Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R
    J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predominance of antibodies to hepatitis C virus envelope proteins in various disease statuses of hepatitis C.
    PodurI CD; Khanna A; Khundmiri SJ; Khaja MN; Kumar KS; Sugunan VS; Habibullah CM; Das MR
    Acta Virol; 2001 Feb; 45(1):1-6. PubMed ID: 11394572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response.
    Bendall R; Ellis V; Ijaz S; Thurairajah P; Dalton HR
    J Med Virol; 2008 Jan; 80(1):95-101. PubMed ID: 18041018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laboratory diagnostics for hepatitis C virus infection.
    Kamili S; Drobeniuc J; Araujo AC; Hayden TM
    Clin Infect Dis; 2012 Jul; 55 Suppl 1():S43-8. PubMed ID: 22715213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of hepatitis C virus (HCV) antibody test systems in relation to HCV-RNA detection in the diagnosis of HCV infection.
    Krarup HB; Jacobsen SE; Varming K; Drewes AM; Madsen PH
    Dan Med Bull; 1998 Feb; 45(1):89-91. PubMed ID: 9504268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies.
    Fournier C; Duverlie G; François C; Schnuriger A; Dedeurwaerder S; Brochot E; Capron D; Wychowski C; Thibault V; Castelain S
    Virol J; 2007 Mar; 4():35. PubMed ID: 17397531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitivity of second-generation enzyme immunoassay for detection of hepatitis C virus infection among oncology patients.
    Macedo de Oliveira A; White KL; Beecham BD; Leschinsky DP; Foley BP; Dockter J; Giachetti C; Safranek TJ
    J Clin Virol; 2006 Jan; 35(1):21-5. PubMed ID: 15921955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Performance of the IgG avidity test in patients with cytomegalovirus disease].
    Lafarga B; Noguera FJ; Bolanos M; Pérez MC; Rodríguez H
    Enferm Infecc Microbiol Clin; 1997 Apr; 15(4):190-5. PubMed ID: 9312277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies to a novel antigen in acute hepatitis C virus infections.
    Tobler LH; Stramer SL; Chien DY; Lin S; Arcangel P; Phelps BH; Cooper SL; Busch MP
    Vox Sang; 2007 Jan; 92(1):1-7. PubMed ID: 17181584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of the immunoglobulin G avidity and enzyme immunoassay IgG/IgM screening tests for differentiation of the clinical spectrum of toxoplasmosis.
    Tanyuksel M; Guney C; Araz E; Saracli MA; Doganci L
    J Microbiol; 2004 Sep; 42(3):211-5. PubMed ID: 15459650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay.
    Alzahrani AJ
    J Med Virol; 2008 Apr; 80(4):603-6. PubMed ID: 18297713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid.
    Kneitz RH; Schubert J; Tollmann F; Zens W; Hedman K; Weissbrich B
    BMC Infect Dis; 2004 Sep; 4():33. PubMed ID: 15355548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of anti-hepatitis C virus (HCV) IgM and HCV-RNA detection in serum samples of patients with HCV infection].
    Lei Z; Lu H; Han F; Shi H; Lu J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):121-3. PubMed ID: 15619814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HCV-RNA and anti-HCV IgM in Egyptian subjects bearing IgG anti-HCV antibodies.
    el-Gohary A; Hosny AM; Fawaz N; Heiba A; Abdalla E; Kawano F; Kiyokawa T
    Jpn J Infect Dis; 1999 Jun; 52(3):113-6. PubMed ID: 10507990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0).
    Myrmel H; Navaratnam V; Asjø B
    J Clin Virol; 2005 Nov; 34(3):211-5; discussion 216-8. PubMed ID: 16112611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity of a modified version of the ARCHITECT Anti-HCV test in detecting samples with immunoblot-confirmed, low-level antibody to hepatitis C virus.
    Echevarría JM; Avellón A; Jonas G; Hausmann M; Vockel A; Kapprell HP
    J Clin Virol; 2006 Apr; 35(4):368-72. PubMed ID: 16406797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humoral immune response to hepatitis C after liver transplantation: assessment of a new recombinant immunoblot assay.
    Rosen HR; Gretch D; Kaufman E; Quan S
    Am J Gastroenterol; 2000 Aug; 95(8):2035-9. PubMed ID: 10950054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of serologically silent occult hepatitis C virus infection by detecting immunoglobulin G antibody to a dominant HCV core peptide epitope.
    Quiroga JA; Castillo I; Llorente S; Bartolomé J; Barril G; Carreño V
    J Hepatol; 2009 Feb; 50(2):256-63. PubMed ID: 19070391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection.
    Ansaldi F; Bruzzone B; Testino G; Bassetti M; Gasparini R; Crovari P; Icardi G
    J Viral Hepat; 2006 Jan; 13(1):5-10. PubMed ID: 16364076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.